RFG
REAP Financial Group Portfolio holdings
AUM
$426M
1-Year Return
12.22%
This Quarter Return
+5.48%
1 Year Return
+12.22%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$364M
AUM Growth
+$21.3M
(+6.2%)
Cap. Flow
+$3.76M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
46.15%
Holding
687
New
34
Increased
140
Reduced
253
Closed
101
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$9.27M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$4.81M |
| 3 |
Avantis US Large Cap Value ETF
AVLV
|
$2.9M |
| 4 |
Avantis Emerging Markets Equity ETF
AVEM
|
$2.82M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
$2.8M |
Top Sells
Sector Composition
| 1 | Technology | 3.04% |
| 2 | Energy | 0.61% |
| 3 | Communication Services | 0.59% |
| 4 | Consumer Discretionary | 0.45% |
| 5 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
T-Mobile US
TMUS
$284B
| $14.4K | ﹤0.01% |
88
+10
| +13% | +$1.64K |
|
327
Pultegroup
PHM
$27.7B
| $14.4K | ﹤0.01% |
119
+19
| +19% | +$2.3K |
|
328
Intuit
INTU
$188B
| $14.3K | ﹤0.01% |
22
-6
| -21% | -$3.91K |
|
329
FMC
FMC
$4.72B
| $14.2K | ﹤0.01% |
223
-169
| -43% | -$10.8K |
|
330
Vertex Pharmaceuticals
VRTX
$102B
| $14.2K | ﹤0.01% |
+34
| New | +$14.2K |
|
331
Labcorp
LH
$23.2B
| $14.1K | ﹤0.01% |
64
+2
| +3% | +$439 |
|
332
AT&T
T
$212B
| $14K | ﹤0.01% |
797
-4,379
| -85% | -$77.1K |
|
333
Honeywell
HON
$136B
| $13.9K | ﹤0.01% |
68
-1
| -1% | -$205 |
|
334
Moody's
MCO
$89.5B
| $13.6K | ﹤0.01% |
35
+3
| +9% | +$1.16K |
|
335
The Communication Services Select Sector SPDR Fund
XLC
$25.8B
| $13.5K | ﹤0.01% |
165
| – | – |
|
336
Lamar Advertising Co
LAMR
$13B
| $13.4K | ﹤0.01% |
112
-661
| -86% | -$79.2K |
|
337
Altria Group
MO
$112B
| $13.4K | ﹤0.01% |
307
-1,551
| -83% | -$67.6K |
|
338
Intel
INTC
$107B
| $13.3K | ﹤0.01% |
301
+78
| +35% | +$3.44K |
|
339
Jabil
JBL
$22.5B
| $13.1K | ﹤0.01% |
98
+11
| +13% | +$1.48K |
|
340
Fifth Third Bancorp
FITB
$30.2B
| $13.1K | ﹤0.01% |
352
-2,391
| -87% | -$89K |
|
341
Healthpeak Properties
DOC
$12.8B
| $13K | ﹤0.01% |
693
-2,203
| -76% | -$41.3K |
|
342
Royal Caribbean
RCL
$95.7B
| $12.9K | ﹤0.01% |
93
+15
| +19% | +$2.09K |
|
343
Invesco Aerospace & Defense ETF
PPA
$6.2B
| $12.9K | ﹤0.01% |
127
| – | – |
|
344
Thermo Fisher Scientific
TMO
$186B
| $12.8K | ﹤0.01% |
22
+1
| +5% | +$582 |
|
345
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$12.6B
| $12.8K | ﹤0.01% |
297
-13
| -4% | -$560 |
|
346
Adobe
ADBE
$148B
| $12.6K | ﹤0.01% |
+25
| New | +$12.6K |
|
347
CACI
CACI
$10.4B
| $12.5K | ﹤0.01% |
33
+2
| +6% | +$758 |
|
348
Vertiv
VRT
$47.4B
| $12.5K | ﹤0.01% |
153
+10
| +7% | +$817 |
|
349
Stryker
SYK
$150B
| $12.4K | ﹤0.01% |
35
| – | – |
|
350
Parker-Hannifin
PH
$96.1B
| $12.3K | ﹤0.01% |
22
-153
| -87% | -$85.3K |
|